Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease — NEJM

Retweeted NEJM (@NEJM): STABILITY: Darapladib does not reduce risk of CV death, myocardial infarction, or stroke. #ACC14 http://t.co/H3jy5Sca4q

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/H3jy5Sca4q